Related Experiment Video
Updated: May 25, 2026
05:12
Transoral Endoscopic Thyroidectomy Vestibular Approach for Thyroid Lobectomy
Published on: May 12, 2023
[Arterial thyroid embolization in thyroid diseases]
Andrzej Jaroszuk1, Grzegorz Kamiński
1Wojskowy Instytut Medyczny w Warszawie, Klinika Endokrynologii i Terapii Izotopowej CSK MON. ajaroszuk@wim.mil.pl
Polski Merkuriusz Lekarski : Organ Polskiego Towarzystwa Lekarskiego
|February 4, 2012
Summary
Arterial embolization offers a minimally invasive alternative for thyroid disease treatment when traditional methods fail. This procedure reduces thyroid hormone production and goiter size, improving outcomes for Graves' disease and thyroid cancer.
Area of Science:
- Interventional Radiology
- Endocrinology
Context:
- Traditional thyroid disease treatments (pharmacotherapy, radioiodine, surgery) have limitations.
- Patient intolerance, side effects, and high surgical risks necessitate alternative therapies.
- Interventional radiology advancements enable arterial embolization for thyroid conditions.
Purpose:
- To evaluate arterial embolization as a therapeutic option for various thyroid diseases.
- To investigate the mechanism of thyroid artery embolization in reducing thyroid function and volume.
- To assess the efficacy and safety of embolization in managing Graves' disease, goiters, and thyroid cancer.
Summary:
- Arterial embolization involves injecting polyvinyl alcohol (PVA) particles into thyroid arteries to block blood flow.
- This induces ischemia, necrosis, and fibrosis, leading to reduced thyroid hormone synthesis and goiter volume.
- Embolization impacts angiogenesis, apoptosis, and autoimmune responses, aiding thyroid function compensation and goiter reduction in Graves' disease.
Impact:
- Preoperative embolization improves surgical outcomes for large goiters and thyroid cancer by reducing hemorrhage and tissue damage.
- Palliative embolization alleviates symptoms and enhances quality of life in advanced thyroid cancer.
- The minimally invasive nature and favorable safety profile make thyroid artery embolization an attractive option for complex clinical scenarios.
Related Concept Videos
01:24Graves Disease II: Pathophysiology
Graves’ disease is an autoimmune disorder characterized by the production of thyroid-stimulating immunoglobulins (TSI) that activate TSH receptors, leading to excessive synthesis and release of thyroid hormones (T3 and T4) and resulting in hyperthyroidism.Among all causes of hyperthyroidism, Graves’ disease is the most common and can happen at any age, though it is more frequent in women. It produces a hypermetabolic state with features such as weight loss, tachycardia, tremor, and heat...
01:27Hyperthyroidism II: Pathophysiology
Hyperthyroidism is a hypermetabolic state caused by elevated levels of thyroid hormones, triiodothyronine (T3) and thyroxine (T4). It results from dysregulation at the thyroid, pituitary, or immune system level and affects multiple organ systems.PathophysiologyThe most common cause of hyperthyroidism is Graves’ disease, an autoimmune disorder in which antibodies, specifically thyroid-stimulating antibodies (TSAb), a subtype of TSH receptor antibodies (TRAb), bind to and activate TSH receptors...
01:28Graves' Disease I: Introduction
Graves' disease is an autoimmune disorder that causes hyperthyroidism, or overactivity of the thyroid gland. It results from autoantibodies called thyroid-stimulating immunoglobulins (TSIs), which bind to thyroid-stimulating hormone (TSH) receptors, leading to overstimulation of hormone production and a hypermetabolic state.EtiologyAlthough considered idiopathic, Graves’ disease has well-established contributing factors. There is a strong genetic component, with increased prevalence in...
01:25Hyperthyroidism I: Introduction
Hyperthyroidism is a type of thyrotoxicosis characterized by the thyroid gland's overproduction of the thyroid hormones triiodothyronine (T3) and thyroxine (T4). This hormone excess increases the basal metabolic rate and enhances sensitivity to catecholamines.DiagnosisDiagnosis is based on clinical features and biochemical testing. It typically shows suppressed thyroid-stimulating hormone (TSH) levels below 0.4 mIU/L, with elevated free T3 and/or T4. Additional tests, including thyroid...
01:23The Thyroid Gland
The thyroid gland is a small, butterfly-shaped gland located in the neck and covers the anterior surface of the trachea. The gland has two lateral lobes connected by a thin tissue mass called the isthmus. Internally, each lobe comprises many small spherical structures known as thyroid follicles, surrounded by a network of blood vessels.
The follicles have a central cavity lined by simple cuboidal to squamous epithelial cells called follicular cells. These cells produce the glycoprotein...
The follicles have a central cavity lined by simple cuboidal to squamous epithelial cells called follicular cells. These cells produce the glycoprotein...
01:27Goiter
Goiter refers to an abnormal enlargement of the thyroid gland that may appear as a diffuse goiter (uniform enlargement) or nodular (single or multiple nodules). Functionally, it is classified as nontoxic (normal/low hormone levels) or toxic (excess hormone production).PathophysiologyDiffuse thyroid enlargement typically results from prolonged stimulation by thyroid-stimulating hormone (TSH) or TSH-like agents, commonly seen in hypothyroidism or iodine deficiency. In contrast, in hyperthyroid...